Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Australian Stock Exchange  >  CSL Limited    CSL   AU000000CSL8

CSL LIMITED

(CSL)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
02/17/2020 02/18/2020 02/19/2020 02/20/2020 02/21/2020 Date
332.55(c) 331.17(c) 341(c) 338.68(c) 336.4 Last
1 023 636 619 205 990 943 1 201 682 686 128 Volume
+0.41% -0.41% +2.97% -0.68% -0.67% Change
More quotes
Financials (AUD)
Sales 2020 13 724 M
EBIT 2020 4 181 M
Net income 2020 3 167 M
Debt 2020 6 471 M
Yield 2020 0,95%
Sales 2021 15 606 M
EBIT 2021 4 933 M
Net income 2021 3 806 M
Debt 2021 6 143 M
Yield 2021 1,12%
P/E ratio 2020 48,3x
P/E ratio 2021 40,2x
EV / Sales2020 11,6x
EV / Sales2021 10,2x
Capitalization 153 B
More Financials
Company
CSL Limited is an Australia-based biotechnology company engaged in the developing and delivering medicines that treat people with rare diseases. It offers treatments for people who are living with conditions in the immunology and neurology; haematology and thrombosis; cardiovascular and metabolic;... 
More about the company
Surperformance© ratings of CSL Limited
Trading Rating : Investor Rating :
More Ratings
Latest news on CSL LIMITED
02/21CSL : Appendix 3G
PU
02/14CSL : University City Science Center partnership with CSL Behring accelerates th..
AQ
02/14CSL : University City Science Center partnership with CSL Behring accelerates th..
AQ
02/12CSL : PRIVIGEN Granted Orphan-Drug Designation for the Investigational Treatment..
AQ
02/11CSL : Media Statement on Coronavirus
PU
02/11CSL : 1st Half Net Profit Rises, Upgrades Full-Year Guidance
DJ
02/06CSL LIMITED : half-yearly earnings release
02/05CSL : HAEGARDA® is now available in the province of Québec for the routine preve..
AQ
01/13CSL : Behring - Researchers Decipher a New Way that Immune Cells Detect Infectio..
AQ
01/13CSL : New way that immune cells detect infections and cancers - Research
AQ
01/10CSL : Process that immune cells use to detect infections and cancers discovered
AQ
01/07Health Care Shares Slip -- Health Care Roundup
DJ
2019GLENMARK PHARMACEUTICALS : announces product approval for Ryaltris in Australia
AQ
2019CSL : Seqirus - New Data Demonstrate that FLUAD Significantly Reduces Hospitaliz..
AQ
2019CSL : Appendix 3B
PU
More news
News in other languages on CSL LIMITED
02/06CSL LIMITED : Veröffentlichung des Halbjahresergebnisses
02/06CSL LIMITED : publication des résultats semestriels
02/05Résumé des principales informations économiques du mercredi 5 février 2020
02/05Les taux de vacance ralentissent mais restent inquiétants
02/05Leere Wohnungen auf dem Land - Wohnungsnot in der Stadt
More news
Analyst Recommendations on CSL LIMITED
More recommendations
Sector news : Biopharmaceuticals
02/21Marriott Hires Former Merck CIO as Tech Chief
DJ
02/21Pharmaceutical companies develop system to better track counterfeit drugs
RE
02/21DAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
02/21ALLERGAN : Form 8.3 -
DJ
02/21ABBVIE : Form 8.3 -
DJ
More sector news : Biopharmaceuticals
Chart CSL LIMITED
Duration : Period :
CSL Limited Technical Analysis Chart | CSL | AU000000CSL8 | MarketScreener
Technical analysis trends CSL LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 312,38  AUD
Last Close Price 336,40  AUD
Spread / Highest target 8,50%
Spread / Average Target -7,14%
Spread / Lowest Target -33,6%
EPS Revisions
Managers
NameTitle
Paul Roger Perreault Chief Executive Officer, Executive Director & MD
Brian Anthony McNamee Chairman
Paul McKenzie Chief Operating Officer
David Mark Lamont Chief Financial Officer
Andrew Cuthbertson Chief Scientific Officer, Director, Director R&D
Sector and Competitors
1st jan.Capitalization (M$)
CSL LIMITED22.82%101 311
BIOGEN INC.13.47%58 609
SAMSUNG BIOLOGICS CO LTD--.--%26 637
ALEXION PHARMACEUTICALS-5.19%22 835
GRIFOLS8.78%22 454
WUXI BIOLOGICS CAYMAN INC0.00%19 461